{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:35:38Z","timestamp":1776605738323,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009563","name":"Fundaci\u00f3n para la Formaci\u00f3n e Investigaci\u00f3n Sanitarias de la Regi\u00f3n de Murcia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009563","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ijcard.2010.09.046","type":"journal-article","created":{"date-parts":[[2010,10,26]],"date-time":"2010-10-26T04:46:18Z","timestamp":1288068378000},"page":"282-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation"],"prefix":"10.1016","volume":"154","author":[{"given":"Almudena","family":"Cascales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"S\u00e1nchez-Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Pastor-Quirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Ayala","family":"de la Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2010.09.046_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2010.03.003","article-title":"Cardiac side-effects of cancer chemotherapy","author":"Monsuez","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0010","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","article-title":"Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults","volume":"22","author":"Hequet","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0015","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside","volume":"26","author":"Gianni","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0020","first-page":"8422","article-title":"Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy","volume":"61","author":"Minotti","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/mol.105.013383","article-title":"Molecular pharmacology of the interaction of anthracyclines with iron","volume":"68","author":"Xu","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/mol.63.4.849","article-title":"Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway","volume":"63","author":"Kwok","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/mol.65.1.181","article-title":"Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents","volume":"65","author":"Kwok","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1096\/fasebj.12.7.541","article-title":"The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase\/iron regulatory protein-1 in cytosolic fractions from human myocardium","volume":"12","author":"Minotti","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0050","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1997.15.4.1318","article-title":"Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer","volume":"15","author":"Swain","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0055","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.jacc.2007.02.060","article-title":"Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model","volume":"49","author":"Panjrath","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GIM.0b013e31819d30f2","article-title":"HFE-associated hereditary hemochromatosis","volume":"11","author":"Alexander","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0065","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood-2003-03-0869","article-title":"Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin","volume":"102","author":"Miranda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0070","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1001\/jama.1978.03290150049023","article-title":"Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals","volume":"240","author":"Friedman","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0075","first-page":"865","article-title":"Anthracycline cardiomyopathy monitored by morphologic changes","volume":"62","author":"Billingham","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0080","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0002-9149(83)90364-8","article-title":"Clinical and morphologic cardiac findings after anthracycline chemotherapy. Analysis of 64 patients studied at necropsy","volume":"51","author":"Isner","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0085","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/j.seminoncol.2006.04.021","article-title":"Anthracycline-induced cardiotoxicity in adult hematologic malignancies","volume":"33","author":"Johnson","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/clinchem\/45.10.1875","article-title":"Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes","volume":"45","author":"Mangasser-Stephan","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0095","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","article-title":"SNPStats: a web tool for the analysis of association studies","volume":"22","author":"Sole","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-0609.1989.tb01229.x","article-title":"Myocardial iron grading by endomyocardial biopsy. A clinico-pathologic study on iron overloaded patients","volume":"42","author":"Barosi","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0105","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2008-04-148767","article-title":"Longitudinal analysis of heart and liver iron in thalassemia major","volume":"112","author":"Noetzli","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"International Hapmap Consortium","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bjp.2008.236","article-title":"Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone","volume":"155","author":"Simunek","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12012-007-0020-6","article-title":"New iron chelators in anthracycline-induced cardiotoxicity","volume":"7","author":"Kaiserova","year":"2007","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0130","first-page":"244","article-title":"Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture","volume":"122","author":"Hershko","year":"1993","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacological therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0140","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","article-title":"Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer","volume":"20","author":"Lipshultz","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0145","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.09.046_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical autorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731000759X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731000759X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:30:22Z","timestamp":1759091422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731000759X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S016752731000759X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.09.046","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.09.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}